1259TiP Investigator-initiated phase II study of nivolumab plus low-dose ipilimumab as first-line therapy for microsatellite instability—high advanced gastric or esophagogastric junction cancer (NO LIMIT, WJOG13320G/CA209-7W7)

Subjects

Subjects :

Oncology
Hematology

Details

ISSN :

09237534

Volume :

33

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........3abda4d25979f0ad70a54344b7024f75

Full Text :

https://doi.org/10.1016/j.annonc.2022.07.1377